JAMA 13 Feb 2013 Vol 309 559 Last week I had a go at the editors of the NEJM and The Lancet for publishing misleadingly reported pharma funded trials, in contradiction to their own idealistically stated views. Now, on p 607, the editor of JAMA maps out the moral high ground which he thinks necessary for […]
Richard Lehman’s journal review—18 February 2013